Updated 07:15 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,856.50 -0.77% CL 89.08 +0.59% BTC 64,493.46 -1.24%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,857 −0.77% BTC $64,493 −1.24% VIX 19.30 +3.21% latest tape · as of 07:15 UTC
The Screen · Financials · Banks - Regional

QCR Holdings, Inc. logoQCR Holdings, Inc.

QCRH · Nasdaq · USD · Market cap $1.7B · 997 employees

QCR Holdings, Inc., a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services.

FAIL · Does not pass the screen
103.99 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price103.99 USD at the 13 Nov 2026 close
  • Our value readFair vs our fair value, as of 13 Nov 2026
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.00)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $96.30 to $145.38, base estimate $113.65 (screen dated 2026-11-13).

Current read
Accumulation ?
Fair · screened 2026-11-13
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.00, read 2026-11-15
  • Ethical does not pass the values gate
Price103.99 USD
Fair value113.65
Ethical score30.0/100
Value readFairas of 13 Nov 2026
Our investment reviews on this name
2026-10-27Read Accumulation97.21+7.0% to today ✓Markdown gives way to Accumulation after a 5% slide in 7 weeks
2026-09-10Read Markdown102.69+1.3% to today Markup gives way to Markdown first Markdown read since July
2026-08-09Read Markup105.05-1.0% to today Markdown gives way to Markup after a 9% rise in 5 weeks
2026-07-02Read Markdown96.33+8.0% to today First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

QCR Holdings, Inc. holds its Accumulation at $103.99. The statistical read favours the sellers, held for 219 days.

As held on the ledger · 2026-11-13
PhaseAccumulation
Quantitative stateThe statistical read favours the sellers, held for 219 days
Price at the screen$103.99
Valuation12.15 trailing · 11.37 forward price to earnings
Values screenFAIL · score 30.0
Beta0.73
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited keyword in sector/industry: bank

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited keyword in sector/industry: bank Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

QCR Holdings, does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when QCRH's ethical verdict changes

Today QCRH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades at roughly an 8% discount to our $113.65 fair value.

How a fair value is estimated: discounted cash flow (DCF).

96.30Conservative113.65Base case145.38Growth case 103.99Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 8.5% discount to the base estimate.

The Street's Range
107.00Street low 111.00Street average 123.00Street high 103.99Price

Third-party analyst targets: 6 covering, consensus Buy. The average target sits +7% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $113.65, with a range of $96.30 to $145.38, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Local Banks Fund Everyday Life But We Pass

Every small business loan or family mortgage in the Midwest runs through a regional player like this one. The numbers show solid revenue growth at 21 percent and a forward P/E of 11.3 times, yet opportunity rating sits at none and the ethical screen blocks any further look.

We stay away because the company fails our ethical screen on the simple fact it operates as a bank. No amount of 37 percent profit margins or 13 percent ROE changes that verdict, even when analyst targets sit a touch above the current price.

Risk sits in the usual banking exposures to interest rates and credit cycles, plus the complete lack of a known moat. The modest margin of safety on paper does not override the hard stop. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E11.4xreasonably valued
Trailing P/E12.1xreasonably valued
EPS, trailing8.50
EPS, forward9.08
Revenue growth-2.5%revenue is shrinking
Profit margin37.6%highly profitable on every dollar of sales
Return on equity12.7%a solid return on shareholder capital
Dividend yield0.44%
Beta0.73steadier than the market
Short interest, float0.03%
52-week range74.78 - 108.11
Market cap$1.7B
Employees997

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

QCRH trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-10 Accumulation $103.26 +1.9% Entry 17

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100.

2026-11-03 Accumulation $101.38 +4.3% Entry 16

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100.

2026-10-27 Accumulation · changed $97.21 +0.0% Entry 15

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100.

2026-10-20 Markdown $97.21 +0.0% Entry 14

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-19 Markdown $97.21 +0.0% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-18 Markdown $97.21 +0.0% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-17 Markdown $97.21 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-16 Markdown $97.21 +0.0% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-15 Markdown $97.21 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-14 Markdown $97.21 +0.0% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 41%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it none, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on QCRH

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in QCRH's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $89.66 +6.6% · $1,066 +6.6%
2 months $90.79 +5.3% · $1,053 +5.3%
3 months $81.81 +16.8% $0.10 $1,169 +16.9%
6 months $87.35 +9.4% $0.16 $1,096 +9.6%
1 year $67.71 +41.1% $0.28 $1,415 +41.5%
2 years $55.18 +73.2% $0.52 $1,741 +74.1%
3 years $44.94 +112.6% $0.76 $2,143 +114.3%
5 years $46.12 +107.2% $1.24 $2,099 +109.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever QCRH does next, these words stay.

QCR Holdings, Inc. · QCRH · Accumulation · $103.99
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.